Dr. Jaroslav Sterba

Dr. Jaroslav Sterba is a highly accomplished medical professional with an extensive background in pediatric oncology. He obtained his Doctor of Medicine degree (M.D.) in 1987, marking the beginning of his impressive career in the field. Dr. Sterba's professional journey started in 1987 when he joined the Department of Pediatrics at the University Hospital Ostrava in the Czech Republic as a resident. He remained there until 1990, after which he completed his pediatric oncology fellowship. Foll...owing this, he assumed the role of Head of the pediatric oncology unit at the same institution from 1993 to 1995. In 1995, Dr. Sterba broadened his horizons and worked as a pediatric oncologist, senior registrar, and acting consultant at the Medical Oncology Department of the Kuwait Cancer Control Center in Kuwait until 1997. Afterward, he returned to the Czech Republic and became a senior lecturer at Masaryk's University, Faculty of Medicine, in Brno from 1997 to 2002. He progressed to the positions of Associated Professor of Pediatrics in 2002 and Professor of Oncology in 2007. Since 1998, Dr. Sterba has served as the Head of the Pediatric Oncology Department at the University Children's Hospital in Brno, Czech Republic, a position he continues to hold. In addition, he served as the Chairman of the NHL committee of the International BFM study group from 2007 to 2011 and as the Vice-Dean of the School of Medicine at Masaryk University in Brno since 2010. Furthermore, Dr. Sterba briefly assumed the role of CEO/Director at the University Hospital Brno, Czech Republic, from 2020 to 2022, highlighting his leadership capabilities and commitment to improving healthcare delivery. Dr. Sterba's expertise and research interests primarily focus on metronomic and precision/personalized therapy in pediatric solid tumors and lymphomas. His remarkable contributions to the field have resulted in the publication of over 290 scientific articles. Throughout his career, Dr. Sterba has held memberships in various prestigious organizations, including the Children's Oncology Group USA (COG) as an International Associate Member, the European Bone and Marrow Transplant Group, the International Society of Pediatric Oncology (SIOP), the Czech medical society J.E. Purkyně, and the Pediatric Committee of the European Medicine Agency. He has also served as the Chair of the Czech Pediatric Oncology Society.